Amazing progress is being made in nuclear medicine in diagnostics and therapeutics.
The field of nuclear medicine is at a crossroads of need and opportunities. Continued development of cell targeted research is showing advancement in therapy beyond traditional cancer treatments and common diagnostic methods using limited supplies of useful isotopes such as short lived beta and alpha emitters. However, it will take a concerted effort on the part of the medical industry, business, and government funding to achieve the needed isotopes and approved procedures.
This pioneering woman physicist received a Nobel Prize for her work in the development of the radioimmunoassay, RIA.
Alan Waltar, nuclear engineer, Past President of the American Nuclear Society: The majority of our citizens are aware of the contributions of nuclear technology to the production of electricity via commercial nuclear power plants. But most are unaware that the impact of this technology is even greater for non-power applications. The world of medicine, agriculture, and modern industry has been substantially improved by the harnessing of radioisotopes, and new applications continue to make major humanitarian contributions to our quality of life.